Retraction Note: Nanoscale Research Letters (2020) 15:196 https://doi.org/10.1186/s11671-020-03416-8
The Editors in Chief have retracted this article. After publication, concerns were raised about the following issues:
Apparent partial overlaps within both images in Fig. 1B.
Panel si-TGFBR3 in Fig. 3E appears to be similar to Fig. 4C, panel ADR (NC) in a previously published article by different authors [1, now retracted].
Panel miR-18a inhibitors in Fig. 3F seem similar to panel pcLINC00472 in Fig. 3B in a previously published paper by different authors [2] and panel CASC2 in Fig. 4c in a previously published paper by yet a different team of authors [3].
The authors did not respond to the request to clarify, as well to provide, raw data and the original ethics approval. The Editors in Chief, therefore, have lost confidence in the findings of this article. The authors did not respond to any correspondence from the Editors about this retraction.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.RETRACTED ARTICLE: Xia W, Liu Y, Du Y, Cheng T, Hu X, Li X. MicroRNA-423 drug resistance and proliferation of breast cancer cells by targeting ZFP36. Onco Targets Ther. 2020; 13:769–782. 10.2147/OTT.S217745. [DOI] [PMC free article] [PubMed] [Retracted]
- 2.Zhang J, Zhang J, Zhang D, et al. Down-regulation of LINC00472 promotes osteosarcoma tumorigenesis by reducing FOXO1 expressions via miR-300. Cancer Cell Int. 2020;20:100. doi: 10.1186/s12935-020-01170-6. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 3.Wang C, Zhao J, Nan X, et al. Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p/PAPD5. Mol Med. 2020;26:74. doi: 10.1186/s10020-020-00200-3. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]